Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans

scientific article

Transforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.68.9.5405-5407.2000
P932PMC publication ID101805
P698PubMed publication ID10948171
P5875ResearchGate publication ID240272510

P50authorA Clinton WhiteQ44838503
Pablo C OkhuysenQ54425139
Prema RobinsonQ58806841
P2093author name stringD E Lewis
P C Okhuysen
A C White
C L Chappell
I Shahab
S Lahoti
P2860cites workA critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cellsQ24678065
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory diseaseQ28202655
Transforming growth factor-beta1 preserves epithelial barrier function: identification of receptors, biochemical intermediates, and cytokine antagonistsQ30304239
Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine.Q30465882
Growth factors in inflammatory bowel diseaseQ33535516
Gastrointestinal mucosal regeneration: role of growth factorsQ33541262
Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis modelQ33654292
Regulatory T cells and inflammatory bowel diseaseQ33740189
Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector functionQ33815039
The infectivity of Cryptosporidium parvum in healthy volunteersQ34319487
Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondiiQ35546330
Granuloma cytokines in murine cysticercosisQ35551593
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondiiQ36367127
Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvumQ39569830
Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammationQ41370537
Healing the epithelium: solving the problem from two sidesQ41371678
Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor betaQ41517331
Intensity of infection in AIDS-associated cryptosporidiosisQ43957052
Virulence of three distinct Cryptosporidium parvum isolates for healthy adultsQ44137804
TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondiiQ44636873
Effector and regulatory lymphoid cells and cytokines in mucosal sites.Q47606873
Interferon‐γ Expression in Jejunal Biopsies in Experimental Human Cryptosporidiosis Correlates with Prior Sensitization and Control of Oocyst ExcretionQ58646616
Intestinal function and injury in acquired immunodeficiency syndrome—related cryptosporidiosisQ58646695
TGF-beta production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient miceQ73748161
The Pathogenesis of Mucosal Inflammation in Murine Models of Inflammatory Bowel Disease and Crohn DiseaseQ74583424
Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvumQ74687192
Site-specific changes in transforming growth factor-alpha and -beta1 expression in colonic mucosa of adolescents with inflammatory bowel diseaseQ78107350
Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin GQ78167287
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectCryptosporidium parvumQ134734
P304page(s)5405-5407
P577publication date2000-09-01
P1433published inInfection and ImmunityQ6029193
P1476titleTransforming growth factor beta1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans
P478volume68

Reverse relations

cites work (P2860)
Q37864135Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans
Q34006110Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.
Q92856287Heat stress, Eimeria spp. and C. perfringens infections alone or in combination modify gut Th1/Th2 cytokine balance and avian necrotic enteritis pathogenesis
Q37704368Human immune responses in cryptosporidiosis
Q90935826Immune response and protective efficacy of Eimeria tenella recombinant refractile body protein, EtSO7, in chickens
Q26765938Infection Strategies of Intestinal Parasite Pathogens and Host Cell Responses
Q39792290Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction
Q36984727Intestinal immune response to human Cryptosporidium sp. infection.
Q40685644Modulation of the immune response by infection with Cryptosporidium spp. in children with allergic diseases.
Q53861788Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice.
Q43893601Oral bovine serum concentrate improves cryptosporidial enteritis in calves
Q47134278Potential Sabotage of Host Cell Physiology by Apicomplexan Parasites for Their Survival Benefits
Q35089632The cell biology of cryptosporidium infection